RAD21 was immunoreactive mainly in the nuclei of HCC cells (Fig. S4); only weak nuclear staining of RAD21 was evident in normal liver cells (Wilcoxon test, P < 0.001). This evidence concerns the gene RAD21 and hepatocellular carcinoma.